The MOLES acronym, scoring system and protocol for managing patients with melanocytic...(C-100515)

CPD
1
11 December 2020
Volume 21, Issue 4

This paper describes a new algorithm - MOLES – to distinguish choroidal naevi from melanomas.

Domains covered

Professionalism Clinical practice

Choroidal naevi can be difficult to distinguish from melanomas, meaning many patients with benign tumours are often referred to hospital eye clinics while urgent treatment of those with melanoma is delayed. Early treatment of choroidal melanoma maximises any opportunities for conserving vision and the eye, possibly preventing metastatic death in some patients. The author describes a new algorithm - MOLES - to highlight the most important indicators of malignancy. Against a backdrop of increasing use of telemedicine and the increasing scope for transferring more of the management of these patients to optometrists in the community, the author suggests that this new system may make it possible for a clinician to diagnose tumours remotely, without the patient having to attend a hospital eye clinic.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

The glaucoma expert on his research and educating the next generation.

The first week of June was Volunteers’ Week, which ushers in the ‘#MonthOfCommunity’. Kathy Oxtoby reports on the personal and professional rewards that volunteering can bring.

This webinar explores anxiety in young adults, with a mental health expert.